Aldose Reductase Inhibition in Diabetes
- 30 July 1984
- journal article
- clinical trial
- Published by Wiley in Diabetic Medicine
- Vol. 1 (2) , 88-90
- https://doi.org/10.1111/j.1464-5491.1984.tb01934.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathyDiabetes, 1983
- A Controlled Trial of Sorbinil, an Aldose Reductase Inhibitor, in Chronic Painful Diabetic NeuropathyDiabetes, 1983
- Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: The effect of aldose reductase inhibitionDiabetologia, 1983
- The effect of an aldose reductase inhibitor (Sorbinil) on the level of metabolites in lenses of diabetic ratsDiabetes, 1983
- Aldose Reductase Inhibition Improves Nerve Conduction Velocity in Diabetic PatientsNew England Journal of Medicine, 1983
- Free and lipid inositol, sorbitol and sugars in sciatic nerve obtained post-mortem from diabetic patients and control subjectsDiabetologia, 1983
- The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic ratsDiabetes, 1982
- CP-45,634: A novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic ratsMetabolism, 1979
- Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes.Journal of Clinical Investigation, 1975
- Metabolic alterations in the human erythrocyte produced by increases in glucose concentrationJournal of Clinical Investigation, 1971